320 related articles for article (PubMed ID: 10294360)
21. [Continuous subcutaneous morphine--treatment of pain in patients with terminal cancer].
Nielsen FB; Clemensen SE; Olesen AS; Hole P
Ugeskr Laeger; 1990 Jun; 152(24):1722-3. PubMed ID: 1694330
[TBL] [Abstract][Full Text] [Related]
22. A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients.
Dudgeon DJ; Bruera E; Gagnon B; Watanabe SM; Allan SJ; Warr DG; MacDonald SM; Savage C; Tu D; Pater JL
J Pain Symptom Manage; 2007 Apr; 33(4):365-71. PubMed ID: 17397698
[TBL] [Abstract][Full Text] [Related]
23. Patient-controlled analgesic infusion pumps.
Health Devices; 2001 May; 30(5):157-85. PubMed ID: 11402779
[TBL] [Abstract][Full Text] [Related]
24. Constant infusion of morphine for intractable cancer pain using an implanted pump.
Hassenbusch SJ; Pillay PK; Magdinec M; Currie K; Bay JW; Covington EC; Tomaszewski MZ
J Neurosurg; 1990 Sep; 73(3):405-9. PubMed ID: 2384779
[TBL] [Abstract][Full Text] [Related]
25. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
Mystakidou K; Befon S; Kouskouni E; Gerolymatos K; Georgaki S; Tsilika E; Vlahos L
Anticancer Res; 2001; 21(3C):2225-30. PubMed ID: 11501851
[TBL] [Abstract][Full Text] [Related]
26. [Management of intractable cancer pain: from intrathecal morphine to cell allograft].
Lazorthes Y; Sallerin B; Verdie JC; Sol JC; Duplan H; Tkaczuk J; Tafani M; Bastide R; Bes JC
Neurochirurgie; 2000 Nov; 46(5):454-65. PubMed ID: 11084478
[TBL] [Abstract][Full Text] [Related]
27. Relative analgesic potency of fentanyl and sufentanil during intermediate-term infusions in patients after long-term opioid treatment for chronic pain.
Reynolds L; Rauck R; Webster L; DuPen S; Heinze E; Portenoy R; Katz N; Charapata S; Wallace M; Fisher DM
Pain; 2004 Jul; 110(1-2):182-8. PubMed ID: 15275766
[TBL] [Abstract][Full Text] [Related]
28. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ
Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of continuous intraspinal narcotic analgesia for chronic pain from benign causes.
Yoshida GM; Nelson RW; Capen DA; Nagelberg S; Thomas JC; Rimoldi RL; Haye W
Am J Orthop (Belle Mead NJ); 1996 Oct; 25(10):693-4. PubMed ID: 8922167
[TBL] [Abstract][Full Text] [Related]
30. [Intraventricular morphine administration as a treatment possibility for patients with intractable pain].
Seiwald M; Alesch F; Kofler A
Wien Klin Wochenschr; 1996; 108(1):5-8. PubMed ID: 8677660
[TBL] [Abstract][Full Text] [Related]
31. Indication for epidural morphine for the relief of intractable pain in advanced oral cancer: report of four cases.
Kayahara H; Hamakawa H; Fukuzumi M; Tanioka H
Br J Oral Maxillofac Surg; 2000 Oct; 38(5):546-9. PubMed ID: 11010793
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of intravenous patient-controlled remifentanil versus morphine anesthesia after coronary artery surgery.
Baltali S; Turkoz A; Bozdogan N; Demirturk OS; Baltali M; Turkoz R; Arslan G
J Cardiothorac Vasc Anesth; 2009 Apr; 23(2):170-4. PubMed ID: 18834819
[TBL] [Abstract][Full Text] [Related]
33. [Continuous subcutaneous morphine to patients with terminal cancer. Analgesia at home].
Laursen JO
Ugeskr Laeger; 1994 Apr; 156(14):2095-6. PubMed ID: 7516101
[TBL] [Abstract][Full Text] [Related]
34. [Home palliative care--2 case reports: a long-term cancer pain management with transdermal fentanyl].
Fujimoto M; Sakuyama T; Mizutani Y; Kuroda T; Yanaga K
Gan To Kagaku Ryoho; 2004 Dec; 31 Suppl 2():190-3. PubMed ID: 15645768
[TBL] [Abstract][Full Text] [Related]
35. [Value of intraventricular morphine analgesia in intractable neoplasm pain. Apropos of 8 cases with self-administration in 4].
Roquefeuil B; Benezech J; Batier C; Blanchet P; Gros C; Mathieu-Daude JC
Neurochirurgie; 1983; 29(2):135-41. PubMed ID: 6888632
[TBL] [Abstract][Full Text] [Related]
36. Tolerance during long-term administration of intrathecal morphine.
Ali NM; Hoffman JS
Conn Med; 1989 May; 53(5):266-8. PubMed ID: 2736913
[TBL] [Abstract][Full Text] [Related]
37. Patient-controlled analgesia for severe cancer pain.
Citron ML; Johnston-Early A; Boyer M; Krasnow SH; Hood M; Cohen MH
Arch Intern Med; 1986 Apr; 146(4):734-6. PubMed ID: 2421659
[TBL] [Abstract][Full Text] [Related]
38. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
[TBL] [Abstract][Full Text] [Related]
39. An audit of acute pain service in Central, Saudi Arabia.
Anwari JS; Ahmed F; Mustafa T
Saudi Med J; 2005 Feb; 26(2):298-305. PubMed ID: 15770310
[TBL] [Abstract][Full Text] [Related]
40. Use of infusion devices for epidural or intrathecal administration of spinal opioids.
Kwan JW
Am J Hosp Pharm; 1990 Aug; 47(8 Suppl):S18-23. PubMed ID: 2202209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
